BSE filing, NSE: LT. Summary written from the filing by ALFA Finder's alert engine.
Larsen & Toubro Ltd: key numbers
- Share price
- ₹3,944.40
- Market cap
- ₹5,54,962 Cr
- Revenue (annual)
- ₹2,85,874 Cr
- Net profit (annual)
- ₹16,084 Cr
- P/E (TTM)
- 31.1×Sector 32.4×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 19.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Larsen & Toubro Ltd
All →Larsen & Toubro Bags ₹1,000 Cr Order
L&T won Significant-band orders for residential towers in Mumbai, Bengaluru, and a commercial tower in Hyderabad. No explicit value stated; band lower bound ₹1,000 Cr.
- Value
- ₹1,000 Cr
- construction towers won
- 19 towers
Larsen & Toubro Merger & Restructuring
L&T has extended the expected completion date for the sale of its entire stake in L&T Network Services to its wholly owned subsidiary Vyoma.AI, now by March 31, 2027. All other earlier terms remain unchanged.
Larsen & Toubro Investor Presentation: Key Takeaways
Q2 FY27 record order inflow ₹1477bn (+28%), revenue ₹787.5bn (+16%), PAT ₹52bn (+33%); EBITDA margin compressed to 8.7%.
Larsen & Toubro Q2 FY27 Results: Net Profit ₹5,949 Cr, Up 27.2% YoY
Larsen & Toubro Ltd reported revenue from operations of ₹78,750 Cr (+15.8% YoY) and net profit of ₹5,949 Cr (+27.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5,949 Cr · +27.2% YoY
Larsen & Toubro Employee Stock Options
L&T's NRC approved allotment of 21,098 equity shares to employees who exercised stock options. The shares rank pari-passu with existing equity.
Larsen & Toubro Bags ₹5,000 Cr Order from Dhaka Mass Transit Company Limited
L&T won Major orders (₹5,000-10,000 Cr) for two Dhaka Metro Line 1 packages from DMTCL. The JICA-funded project spans 31 km with 19 stations.
- Value
- ₹5,000 Cr
- From
- Dhaka Mass Transit Company Limited (DMTCL)
- metro track length
- 31 km
Other other announcement announcements
All →Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.